Pharmaceuticals, Biotechnology and Life Sciences
EMERYVILLE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage biotherapeutics company harnessing the…
Assigned PDUFA target action date of March 22, 2023SAN DIEGO, Sept. 20, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ:…
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company…
— 5-fold higher neutralizing antibodies against dominant Omicron BA.5 in participants who received SCB-2019 (CpG 1018/Alum) as a heterologous third…
VANCOUVER, British Columbia, Sept. 19, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader…
SAN DIEGO, Sept. 19, 2022 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies,…
LA JOLLA, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
Congress Moves to Expand Funding for National Network of Specialized Treatment Centers and Community Organizations for Sickle Cell Disease PatientsSOUTH…
All director nominees reelected for the coming yearAll other proposals also approved by shareholders TORONTO and CHICAGO, Sept. 15, 2022…
WOBURN, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,…